1. Home
  2. RLAY vs HUN Comparison

RLAY vs HUN Comparison

Compare RLAY & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$14.78

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$15.71

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
HUN
Founded
2015
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
RLAY
HUN
Price
$14.78
$15.71
Analyst Decision
Strong Buy
Hold
Analyst Count
10
11
Target Price
$19.50
$12.09
AVG Volume (30 Days)
4.6M
3.9M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
2.64%
EPS Growth
31.78
N/A
EPS
N/A
N/A
Revenue
$15,355,000.00
$5,683,000,000.00
Revenue This Year
N/A
$3.08
Revenue Next Year
$324.03
$5.27
P/E Ratio
N/A
N/A
Revenue Growth
53.44
N/A
52 Week Low
$2.98
$7.30
52 Week High
$17.47
$15.90

Technical Indicators

Market Signals
Indicator
RLAY
HUN
Relative Strength Index (RSI) 57.36 63.24
Support Level $11.68 $13.13
Resistance Level $15.45 N/A
Average True Range (ATR) 1.03 0.54
MACD 0.01 0.03
Stochastic Oscillator 42.02 87.85

Price Performance

Historical Comparison
RLAY
HUN

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

Share on Social Networks: